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Phosphatidylinositol 4-kinases (PI4Ks) and small guanosine triphosphatases (GTPases) are essential for processes that require expansion and remodeling of phosphatidylinositol 4-phosphate (PI4P)-containing membranes, including cytokinesis, intracellular development of malarial pathogens, and replication of a wide range of RNA viruses. However, the structural basis for coordination of PI4K, GTPases, and their effectors is unknown. Here, we describe structures of PI4Kb (PI4KIIIb) bound to the small GTPase Rab11a without and with the Rab11 effector protein FIP3. The Rab11-PI4KIIIb interface is distinct compared with known structures of Rab complexes and does not involve switch regions used by GTPase effectors. Our data provide a mechanism for how PI4KIIIb coordinates Rab11 and its effectors on PI4P-enriched membranes and also provide strategies for the design of specific inhibitors that could potentially target plasmodial PI4KIIIb to combat malaria.
I
ntracellular compartments are essential to eukaryotic cell biology, and both small guanosine triphosphatases (GTPases) and lipids such as phosphoinositides are key components of compartment identity (1, 2). The phosphatidylinositol 4-kinases (PI4Ks) and the small G-protein Rab11 play prominent roles in compartment identity. PI4KIIIb is one of four mammalian PI4K enzymes that phosphorylate phosphatidylinositol to generate phosphatidylinositol 4-phosphate (PI4P). PI4KIIIb localizes primarily at the Golgi and is essential for Golgi formation and function (3) (4) (5) . PI4P is recognized by protein modules, including the PH domains of oxysterol-binding protein, ceramide transfer protein, and four-phosphate-adaptor protein, that are important for intra-Golgi transport (6) (7) (8) . However, typically, lipid recognition alone is not sufficient for Golgi localization, which requires both PI4P and specific small GTPases. In addition to its catalytic role in synthesizing PI4P, PI4KIIIb also has noncatalytic roles that rely on the interactions with other proteins such as the small GTPase Rab11 (9) . Rab11 is predominately located on recycling endosomes (10) . However, Rab11 is also found associated with Golgi membranes, which requires an interaction with PI4KIIIb (9).
PI4KIIIb activity is essential for replication of a range of RNA viruses, including enteroviruses, SARS coronavirus, and hepatitis C virus (11, 12) . These RNA viruses hijack the activity of host cell PI4KIIIb to generate replication organelles enriched in PI4P. There is no approved antiviral therapy for enteroviruses. However, several compounds inhibit enteroviral replication by targeting cellular PI4KIIIb (13, 14) . PI4KIIIb is also important in malaria, and inhibitors of Plasmodium falciparum PI4KIIIb are potent antimalarial agents. However, mutations in both PI4KIIIb and Rab11 confer resistance to these compounds (15) . Inhibition of P. falciparum PI4KIIIb prevents the membrane ingression that occurs during completion of the asexual erythrocytic stage of the plasmodial life cycle. The role of Plasmodium Rab11 and PI4KIIIb in membrane remodeling is similar to the role of Rab11 and PI4KIIIb in cytokinesis in Drosophila spermactocytes (16) . In Drosophila, PI4KIIIb is required for the recruitment of both Rab11 and its downstream effectors.
To understand how PI4KIIIb can both recruit Rab11 and enable its interactions with Rab11 effectors, we used hydrogen-deuterium exchange mass spectrometry (HDX-MS) to facilitate the x-ray crystal structure of human PI4KIIIb in complex with Rab11a-GTPgS [GTPgS, guanosine 5´-O-(3´-thiotriphosphate)] at 2.9 Å resolution (see supplementary materials and methods). To form crystals, highly flexible regions of PI4KIIIb identified by HDX-MS were truncated (residues 1 to 120, 408 to 507, and 785 to 801) (Fig. 1A ). This included a C-terminal region necessary for catalytic activity ( fig. S2A ). The PI4KIIIb structure consists of two domains, a right-handed helical solenoid (residues 128 to 243) and a kinase domain (residues 306 to 801) (Fig. 1B) , that are related to the PI3Ks ( fig. S3 ). The kinase domain has two lobes, an N-terminal lobe dominated by a five-stranded antiparallel b sheet and a C-terminal lobe that is largely helical, with the adenosine triphosphate (ATP)-binding site located in a cleft between the lobes. The N lobe of PI4KIIIb has a PI4KIIIb-distinct, large insertion (residues 391 to 539) (Fig. 1B ).
PI4KIIIb makes a distinct interaction with Rab11a that is not characteristic of any Rab or Arf effector (17) . This interaction involves primarily helix a3 of the PI4KIIIb helical domain (Figs. 1B and 2A). Because a previous study of human PI4KIIIb mapped the epitope interacting with Rab11a to the insertion in the N lobe of the kinase domain (9), we also used HDX-MS to determine the Rab11 binding site on full-length PI4KIIIb in solution (figs. S4 and S5). The HDX-MS measurements confirmed the interaction between the N-terminal part of the PI4KIIIb helical domain and Rab11a ( fig. S5 ). Soluble Rab11 had no effect on PI4KIIIb activity (fig. S2B) .
The PI4KIIIb-Rab11 interface is predominantly hydrophobic, with no hydrogen bonds or salt links ( Fig. 2A) . Surprisingly, PI4KIIIb makes only a single, peripheral contact with the Rab11 switch I (only with the edge residues 38-LES-40 of switch I) and no contact with switch II (Fig. 2,  A and B) . The switch regions change conformation depending on whether Rab11 is bound to GTP or guanosine diphosphate (GDP). Consistent with the structure, PI4KIIIb bound both GTP-and GDP-loaded Rab11, with a slight preference for GTP ( Fig. 2D and fig. S6 ). Within the PI4KIIIb-Rab11 interface, G155 (18) of PI4KIIIb makes a direct contact with the ribose moiety of GTPgS bound to the Rab11 (Fig. 2A) . The small residue at position 155 is completely conserved among PI4KIIIb homologs, from yeast to mammals, and might be required to maintain the contact with Rab11. Indeed, a PI4KIIIb-G155D mutation (where G155D denotes Gly 155 →Asp 155 ) decreased binding to Rab11 (Fig. 2, C and D) . Consistent with PI4KIIIb directly contacting the nucleotide, PI4KIIIb decreased the rate of EDTA-mediated Rab11 nucleotide exchange (fig. S2C ). PI4KIIIb residues Y159, N162, and F165 also form prominent contacts with the Rab11. The mutants PI4KIIIb-Y159A, N162A, and F165A and the double mutant Y159A/N162A all eliminated measurable binding to Rab11 (Fig. 2,  C and D) . The Rab11 residues interacting with PI4KIIIb are all conserved among Rab11a and Rab11b, but not among other Rabs that do not bind PI4KIIIb (Fig. 2B) . The PI4KIIIb residues interacting with Rab11 are also strongly conserved among PI4KIIIb orthologs (Fig. 2B and fig. S3 ).
The (16) . During interphase, FIP3 is required for the structural integrity of the pericentriolar recycling endosome compartment (20) , whereas during cytokinesis, it is involved in delivering material from recycling endosomes to the cleavage furrow (21) . The FIP proteins interact with Rab11 using a conserved C-terminal region known as the Rab-binding domain (RBD). Two FIPs form a parallel coiled-coil dimer with two Rab11 binding sites (22-24) that engage both switch I and switch II of Rab11.
The structure of Rab11a bound to the RBD domain of FIP3 (22-24) and our structure of the PI4KIIIb-Rab11a complex suggest that a ternary complex might be formed. Glutathione S-transferase (GST) pulldowns carried out with the GST-tagged RBD domain from FIP3 (residues 713 to 756) revealed that the complex of the FIP3-RBD with GTPgS-loaded Rab11a (Q70L) was able to bind PI4KIIIb (Fig. 3A) . To understand how this occurs, we crystallized a ternary PI4KIIIb/Rab11a/FIP3-RBD complex. Although this is a low-resolution (6 Å) structure with a very large asymmetric unit (~1 MD, containing 12 ternary complexes), both FIP3 and PI4KIIIb were bound simultaneously to Rab11a-GTPgS (Fig. 3B and fig. S7 ). The ability of PI4KIIIb to recruit both Rab11a and its downstream effectors is unlikely to be limited to only the FIP family of proteins. The production of PI4P by Pik1, the yeast ortholog of PI4KIIIb, is required for the Ypt32 (yeast ortholog of Rab11)-dependent recruitment of the Rab guanine nucleotide exchange factor Sec2p (25), in a phosphoinositide-dependent regulation of Rab activation cascade. The conservation of the PI4KIIIb-Rab11a interface in Pik1 and Ypt32 indicates the possibility of a ternary Pik1-Ypt32-Sec2 complex. Furthermore, the switch-independent interaction of PI4KIIIb with Rab11 suggests that ternary PI4KIIIb/Rab11/RabGAP and PI4KIIIb/Rab11/Rab Escort complexes could also be formed ( fig. S8 ).
The inhibitor PIK93 shows a clear selectivity for PI4KIIIb over PI4KIIIa, with partial selectivity over PI3Ks (26) . This inhibitor has been used to decipher PI4K-specific functions (27) , for example, in demonstrating the role of PI4KIIIb in viral replication (11) . PIK93 bound in the ATP-binding pocket, using its thiazol and acetamide moieties to make a pair of hydrogen bonds with the backbone of V598 in the hinge between the N and C lobes (Fig. 4A and fig. S9A ). The PI4KIIIb ATP-binding pocket and those of PI3Ks and phosphatidylinositol 3-kinase-related kinases show considerable consistency. Most of the contacts that PIK93 makes with PI4KIIIb involve residues that are conserved among both the PI3Ks and PI4Ks (Fig. 4, A and C) . The PIK93 sulfamoyl moiety makes a hydrogen bond with K549 of PI4KIIIb. Although this lysine is conserved in the PI3Ks, its conformation is variable, and in the structures of PIK93 in complex with either p110g (26) or Vps34 (28), the equivalent lysine does not make this hydrogen bond ( fig. S9B ).
PI4KIII β Helical
There is more sequence divergence in the residues near the hinge. Though the class III PI3K Vps34 is more closely related to PI4KIIIb than other PI3Ks, PIK93 is a poor inhibitor of Vps34. The PI4KIIIb has a great deal of space near the hinge that allows PIK93 to form hydrogen bonds with the hinge and simultaneously optimize contacts elsewhere ( fig. S9B ). Y583 packs against the hinge to form one wall of the pocket contacting both the Cl substituent of the thiazole and the phenyl moiety. The structure helps rationalize why a Y583M mutation makes PI4KIIIb insensitive to wortmannin and PIK93 (29) (fig. S9C ).
Inhibitors specific against plasmodial PI4KIIIb are potent antimalarial agents, and resistance mutations in either Rab11a or PI4KIIIb can evade the antimalarial activity of these compounds (15) . The plasmodial Y1356F resistance mutation involves the hinge residue, which is equivalent to human P597. It may be that Y1356 makes an additional interaction with the inhibitor (Fig.  4, B and D) . The S1320L resistance mutation corresponds to F561 in human PI4KIIIb. This residue packs against Y583 (Y1342 in P. falciparum), which forms one wall of the inhibitor-binding pocket, and the mutation may alter the conformation of the pocket. The third mutation, H1484Y, is in a bend between ka8 and ka9 and is equivalent to H728 in human PI4KIIIb. Several somatic mutations associated with cancer have been detected for human p110a PI3K in the equivalent bend, and the most common of these mutations increases enzymatic activity and membrane binding (30) . It is plausible that the H1484Y resistance mutation is making PI4KIIIb more active.
The structures of a binary complex of PI4KIIIb with Rab11a and a ternary complex of PI4KIIIb with Rab11a and Rab11-effector FIP3 revealed a Rab11 interface that is compatible with the PI4KIIIb-driven recruitment of Rab11 and its effectors to PI4P-enriched membranes. PI4KIIIb plays key roles in regulating Rab11a in cytokinesis of spermatocytes, recruitment of Rab guanine nucleotide exchange factors in yeast, and membrane remodeling in Plasmodium development. The PI4KIIIb-Rab11 interface is conserved and demonstrates that PI4K, in addition to its kinase activity, plays key kinase-independent roles in mediating these membrane-trafficking events. This structure opens up exciting prospects for the development of highly specific inhibitors, which may act as potent antimalarial and antiviral therapeutics.
